PRAX (Praxis Precision Medicines, Inc.) Stock Financials & Earnings

PRAXPraxis Precision Medicines, Inc.

Mkt Cap$7B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$303M

EPS (TTM)-$13.46

Free Cash Flow (TTM)-$249M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth-100.0%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$683K	-$25M	-$38M
Q2 23	$781K	-$25M	-$35M
Q3 23	$468K	-$17M	-$26M
Q4 23	$515K	-$18M	-$28M
Q1 24	$431K	-$27M	-$42M
Q2 24	$357K	-$27M	-$37M
Q3 24	$302K	-$42M	-$57M
Q4 24	$7M	-$49M	-$64M
Q1 25	$0	-$61M	-$75M
Q2 25	$0	-$63M	-$76M
Q3 25	$0	-$66M	-$78M
Q4 25	$0	-$28K	-$97M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Quarter	License
Q1 23	$700K
Q2 23	$800K

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$81M	$5M	$86M
Q2 23	$124M	$0	$124M
Q3 23	$101M	$0	$101M
Q4 23	$81M	$0	$81M
Q1 24	$152M	$55M	$207M
Q2 24	$145M	$207M	$352M
Q3 24	$169M	$188M	$357M
Q4 24	$215M	$177M	$393M
Q1 25	$166M	$162M	$328M
Q2 25	$157M	$144M	$301M
Q3 25	$150M	$118M	$267M
Q4 25	$357M	$242M	$599M

Shares Outstanding

Revenue Per Employee

Revenue / Employee